Cancer Stem Cells in Multiple Myeloma
Cancer Stem Cells in Multiple Myeloma
In multiple myeloma "cancer stem" cells can be defined and quantified with flow cytometry.
 More, these cells can be related to treatment response.
The investigators' hypothesis is that, multiple myeloma plasma cells derivate from principal
 cells that is called "cancer or progenitor stem cell". In multiple myeloma to define
 immunophenotyping features of these "cancer stem cells" with flow cytometry and to show their
 prognostic value and check for any relationship between cancer stem cell quantification and
 chemotherapy response are main aims of this study.
Inclusion Criteria:

 -  New Diagnosed or Relapsed Multiple Myeloma

 -  Routine Bone Marrow Aspiration will be done

 Exclusion Criteria:

 -  Bone Marrow Aspiration is not Needed